Treatment
Share your love
All You Need to Know about Trabeculectomy
Trabeculectomy is a surgical procedure primarily used to treat glaucoma, a group of eye conditions characterized by damage to the optic nerve, often due to abnormally high pressure in the eye. As one of the most commonly performed surgeries for…
Iridotomy: Indications, Benefits and Risks
What Is Iridotomy? Iridotomy, often referred to as laser iridotomy, is a surgical procedure aimed at treating certain types of glaucoma and other eye conditions that cause an abnormal increase in intraocular pressure (IOP). It involves creating a tiny hole…
OMNI Surgical System Greatly Reduces Medication Usage
Sight Sciences released study findings demonstrating that patients with glaucoma who had undergone procedures using their OMNI Surgical System technology had a greater average reduction in the usage of intraocular pressure-lowering medication compared to those who had received only minimally…
Iridex 532 and Iridex 577 Lasers Introduced in the US
Iridex has launhed its latest laser platforms, the Iridex 532 and Iridex 577 lasers, in the United States. The company highlights that both lasers are equipped with multiple treatment modes, incorporating continuous-wave and the proprietary MicroPulse technology. The devices boast…
Belkin’s Eagle Device FDA Cleared for Laser Trabeculoplasty
Belkin Vision has received FDA 510(k) clearance for its Eagle device, a Q-switched, 532 nm-wavelength, frequency-doubled Nd:YAG laser developed for selective laser trabeculoplasty (SLT). The Eagle is positioned by Belkin as the first and only contactless laser for glaucoma, offering…
FDA Warms 8 Companies for Unapproved Eye Items
On Monday, the US Food and Drug Administration (FDA) took action by sending warning letters to several companies, including CVS and Walgreens, due to concerns regarding the manufacturing and marketing of unapproved eye products. According to the FDA, these products…
Pioneering Glaucoma Therapy: $2M Research Grant Awarded
Researchers at Indiana University School of Medicine are embarking on a groundbreaking mission to develop a new therapy for glaucoma, a disease that can lead to blindness. This endeavor is made possible by a newly awarded five-year, $2 million R01…
Carl Zeiss Meditec to Acquire D.O.R.C.
Carl Zeiss Meditec AG announced that they have entered into an agreement to acquire 100% of the shares in D.O.R.C. Dutch Ophthalmic Research Center (International) B.V. from Eurazeo SE, based in Paris, France. The deal is worth €985 million (nearly…
RevOpsis Raises $16.5M for Wet AMD Treatment
RevOpsis Therapeutics has announced the successful closure of its first seed funding round, securing a total of $16.5 million. This funding is set to advance the development and commercialization of treatments for chronic multifactorial diseases through the company’s innovative, fully…
5 Dos and 5 Don’ts After Laser Eye Surgery
Laser eye surgery has become a popular solution for correcting vision problems such as nearsightedness, farsightedness, and astigmatism. While the procedure is known for its high success rate and quick recovery times, proper post-operative care is crucial to achieve optimal…